“Re-educating” tumor-associated macrophages by targeting NF-κB
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The nuclear factor κB (NF-κB) signaling pathway is important in cancer-related inflammation and malignant progression. Here, we describe a new role for NF-κB in cancer in maintaining the immunosuppressive phenotype of tumor-associated macrophages (TAMs). We show that macrophages are polarized via interleukin (IL)-1R and MyD88 to an immunosuppressive “alternative” phenotype that requires IκB kinase β–mediated NF-κB activation. When NF-κB signaling is inhibited specifically in TAMs, they become cytotoxic to tumor cells and switch to a “classically” activated phenotype; IL-12high, major histocompatibility complex IIhigh, but IL-10low and arginase-1low. Targeting NF-κB signaling in TAMs also promotes regression of advanced tumors in vivo by induction of macrophage tumoricidal activity and activation of antitumor activity through IL-12–dependent NK cell recruitment. We provide a rationale for manipulating the phenotype of the abundant macrophage population already located within the tumor microenvironment; the potential to “re-educate” the tumor-promoting macrophage population may prove an effective and novel therapeutic approach for cancer that complements existing therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. IKKβ inhibition increases macrophage tumoricidal activity. (A) WT, MyD88−/−, TLR-2−/−, and TLR-4−/− or mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8-Luc in a modified Boyden chamber without direct cell–cell contact for 72 h. In addition, CD11b+-selected TAMs from the ascites of ID8 tumor–bearing mice were mock (TAMmock) or IKKβDN infected (TAMDN). Invasion of ID8-Luc cells was assessed by luciferase activity in the lower part of the chamber. Macrophages deleted in MyD88, IL-1R, or IKKβ significantly reduce ID8-Luc invasion (P < 0.01; t test with Welch's correction). Data are represented as mean ± SEM of n = 6. Representative data are shown from at least three independent experiments. (B) ID8 cells were co-cultured with IKKβ-targeted BMDMs or TAMs and respective control cells. Fluorescence caspase 3/7 activity was assessed after 0, 3, and 6 h. Co-culture with IKKβDN and IKKβΔ BMDMs or TAMs expressing IKKβDN (TAMDN) significantly increases caspase 3/7 activity in ID8 cells (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 6. Representative data are shown from at least three independent experiments. (C) [111In]oxine release assay after a 24-h co-culture of 111In-labeled ID8 cells with mock, IKKβDN, TAMDN or IKKβf/f, and IKKβΔ macrophages. 111In-release in cell-free culture supernatants was measured after 24 h with a scintillation counter. IKKβ-targeted macrophages promote increased cytotoxicity. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.](https://figures.cochat.ai/paper-figures/741fab83e5184295af0f590a594611ed/re-educating-tumor-associated-macrophages-by-targeting-nf-b-figure-1.jpg)
![Figure 2. IKKβ maintains the alternative phenotype of tumor-polarized macrophages. WT, mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8 cells for 24 h. Supernatant was collected after 24 h and analyzed for IL-10, IL-12p70, TNF-α, and NO production by ELISA. (A) Co-cultured WT macrophages express an immunosuppressive IL-10high IL-12p70low TNF-αhigh profile. However, supernatant from co-cultured IKKβ-deleted macrophages show a significant decrease in IL-10 and TNF-α (P < 0.01; t test with Welch's correction) but increase in IL-12p70 (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 3. Representative data are shown from at least three independent experiments. (B) In parallel, total RNA was isolated for real-time PCR analysis of IL-12p40 and arginase-1 in co-cultured macrophages. Targeting IKKβ in macrophages switches their phenotype to an IL-12high arginase-1low NOS2high profile, consistent with an M1 phenotype. In_addition, IKKβ-targeted macrophages secrete significantly higher levels of NO, measured as nitrite by Griess assay (P < 0.01; Mann-Whitney test). Data are represented as mean ± SD of n = 3. Representative data are shown from at least four independent experiments. (C) Macrophages were co-cultured with ID8 cells, and protein extracts were prepared at the indicated time points for biochemical analysis. Expression of NF-κB p65, serine 536 phosphorylation of p65, IKKβ, Stat1, tyrosine 701 phosphorylation of Stat1 (Tyr701), and NOS2 was measured by immunoblot analysis of cell lysates using β-actin as a loading control. Representative data are shown from at least three independent experiments. (D) [111In]oxine release assay after co-culture of ID8 ovarian cancer cells with IKKβDN or IKKβΔ BMDMs. IKKβ-targeted macrophages promote increased cytotoxicity that was reversed by the addition of the selective NOS2 inhibitor 1400W. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.](https://figures.cochat.ai/paper-figures/2ca0616e0f4f417d8bd81ac7dc101f6c/re-educating-tumor-associated-macrophages-by-targeting-nf-b-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
Xie, Q.-W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., & Nathan, C. (1992) · Science · doi:10.1126/science.1373522 · Cited by 1,886
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Self-citationColony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018
Cited by
Items 201–300 of 802
Cancer-Derived Exosomes as Effectors of Key Inflammation-Related Players
Othman, N., Jamal, R., & Abu, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02103 · Cited by 118
“The balance between the anti-tumor and pro-tumor properties of macrophages is demonstrated to be regulated by NF-κB, thus NF-κB can be targeted to favor the anti-tumor macrophage function (15, 16).”
BackgroundCombinatorial therapy in tumor microenvironment: Where do we stand?
Kumari, S., Advani, D., Sharma, S., Ambasta, R. K., & Kumar, P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188585 · Cited by 130
Neyen, C. D., Plüddemann, A., Mukhopadhyay, S., Maniati, E., Bossard, M., Gordon, S., & Hagemann, T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203194 · Cited by 126
“We previously reported a syngeneic model of ovarian cancer using a luciferase-labeled cell line ID8 (33).”
MethodSelf-citationMattiola, I., Pesant, M., Tentorio, P., Molgora, M., Marcenaro, E., Lugli, E., Locati, M., & Mavilio, D. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500325 · Cited by 136
Komohara, Y., Niino, D., Saito, Y., Ohnishi, K., Horlad, H., Ohshima, K., & Takeya, M. (2013) · Cancer Science · doi:10.1111/cas.12167 · Cited by 113
Kudo, S., & Nagasaki, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.019 · Cited by 122
Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression
Ma, R., Ji, T., Chen, D., Dong, W., Zhang, H., Yin, X., Ma, J., Liang, X., Zhang, Y., Shen, G., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1118599 · Cited by 117
The role of tumor-associated macrophages in tumor vascularization
Guo, C., Buranych, A., Sarkar, D., Fisher, P. B., & Wang, X.-Y. (2013) · Vascular Cell · doi:10.1186/2045-824x-5-20 · Cited by 114
“For example, signals derived from stromal and inflammatory cells, hypoxia, genetic or epigenetic changes of cancer cells [20], as well as several molecular signaling pathways, including NF-κB [23,38], Notch [39] and Wnt5a [40], are important regulators of polarization of TAMs.”
Ho, M.-Y., Tang, S., Chuang, M., Cha, T., Li, J.-Y., Sun, G.-H., & Sun, K. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0160 · Cited by 125
Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
Sarode, P., Schaefer, M. B., Grimminger, F., Seeger, W., & Savai, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00324 · Cited by 117
miRNA-223 at the crossroads of inflammation and cancer
Jeffries, J., Zhou, W., Hsu, A. Y.-H., & Deng, Q. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.051 · Cited by 129
Circulating and Tumor-Infiltrating Myeloid Cells Predict Survival in Human Pleural Mesothelioma
Burt, B. M., Rodig, S. J., Tilleman, T. R., Elbardissi, A. W., Bueno, R., & Sugarbaker, D. J. (2011) · Cancer · doi:10.1002/cncr.26143 · Cited by 115
“Furthermore, inhibiting the altered NF-jb signaling in murine TAM generates cytotoxic antitumor macrophages.(51) Taken together, given the sheer numbers of tumor-infiltrating macrophages already in strategic position within MPM tumors and the altered myeloid immune response noted in these patients, manipulation of mye…”
BackgroundRole of Macrophage Polarization in Tumor Angiogenesis and Vessel Normalization
Chen, P., & Bonaldo, P. (2013) · International review of cytology · doi:10.1016/b978-0-12-407704-1.00001-4 · Cited by 127
Spear, P., Barber, A., Rynda-Apple, A., & Sentman, C. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103019 · Cited by 111
“moting properties, subpopulations of macrophages can support tumor rejection and promote anti-tumor immune responses elicited by cancer immunotherapies (3, 4).”
BackgroundResultInfluentialLeblond, M. M., Gérault, A. N., Corroyer-Dulmont, A., MacKenzie, E. T., Petit, E., Bernaudin, M., & Valable, S. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1056442 · Cited by 106
Kiaii, S., Clear, A. J., Ramsay, A. G., Davies, D., Sangaralingam, A., Lee, A., Calaminici, M., Neuberg, D. S., & Gribben, J. G. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.2137 · Cited by 104
“Tumor cells alter cytolytic T cells(11) and recruitment of protumor macrophages.(12,13) CD4 and CD8 tumor-infiltrating lymphocytes (TILs) in FL have impaired function and suppressed recruitment of critical signaling proteins to the immunologic synapse.”
BackgroundAlternative activation of macrophages by IL‐4 requires SHIP degradation
Weisser, S. B., McLarren, K. W., Voglmaier, N., van Netten‐Thomas, C. J., Antov, A., Flavell, R. A., & Sly, L. M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041105 · Cited by 109
Zhang, J., Hu, Z., Horta, C. A., & Yang, J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.002 · Cited by 114
“demonstrated that NF- κB inhibition reprogramed M2 macrophages to M1 macrophages and repressed tumor growth by increasing IL-12-dependent NK activity[332].”
BackgroundEngineered materials for cancer immunotherapy
Cheung, A. S., & Mooney, D. J. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.007 · Cited by 111
Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
Yin, M., Shen, J., Yu, S., Jing, F., Zhu, X., Zhao, J., Zhai, L., Sadhukhan, A., & Zhou, J. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s216355 · Cited by 111
Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer
McLoed, A. G., Sherrill, T. P., Cheng, D.-S., Han, W., Saxon, J. A., Gleaves, L. A., Wu, P., Polosukhin, V. V., Karin, M., Yull, F. E., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.085 · Cited by 107
Niu, M., Naguib, Y. W., Aldayel, A. M., Shi, Y.-C., Hursting, S. D., Hersh, M. A., & Cui, Z. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500565q · Cited by 111
Complement 5a stimulates macrophage polarization and contributes to tumor metastases of colon cancer
Piao, C., Zhang, W.-M., Li, T.-T., Zhang, C.-C., Qiu, S., Liu, Y., Liu, S., Jin, M., Jia, L.-X., Song, W.-C., et al. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.03.009 · Cited by 106
“Recent studies have suggested the requirement for NF-κB signaling to maintain the TAM phenotype in a mouse ovarian cancer model [58].”
BackgroundJiang, X., Zhou, T., Xiao, Y., Yu, J., Dou, S., Chen, G., Wang, R., Xiao, H., Hou, C., Wang, W., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1211219 · Cited by 103
“Biased M2 macrophage polarization also contributes to tumor progression and metastasis in colon cancer and other tissues(31-33) and macrophage re-education has been considered as a microenvironment-targeted therapy.(34,35) For this purpose, factors determining the diversity of macrophages are under intensive investiga…”
BackgroundNF-κB role on tumor proliferation, migration, invasion and immune escape
Khan, A., Zhang, Y., Ma, N., Shi, J., & Hou, Y. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00811-6 · Cited by 115
Reversible differentiation of pro- and anti-inflammatory macrophages
Xu, W., Zhao, X., Daha, M. R., & van Kooten, C. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.07.005 · Cited by 116
“in response to microenvironmental signals, as shown by numerous studies in mice (Hagemann et al., 2008; Kawanishi et al., 2010; Mylonas et al., 2009; Rutschman et al., 2001; Stout et al., 2005; Stout and Suttles, 2004).”
BackgroundCancer stem cells and differentiation therapy
Jin, X. J., Jin, X., & Kim, H. (2017) · Tumor Biology · doi:10.1177/1010428317729933 · Cited by 113
Zhao, Y., Zheng, Y., Zhu, Y., Li, H., Zhu, H., & Liu, T. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01526-2 · Cited by 99
Mukherjee, S., Baidoo, J., Sampat, S., Mancuso, A., David, L., Cohen, L. S., Zhou, S., & Banerjee, P. (2018) · Molecules · doi:10.3390/molecules23010201 · Cited by 107
“These activated NK cells play a major role in maintaining the M1-like state of the TAM and also in the killing of tumor cells [51].”
BackgroundTrajectory analysis quantifies transcriptional plasticity during macrophage polarization
Liu, S. X., Gustafson, H. H., Jackson, D. L., Pun, S. H., & Trapnell, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-68766-w · Cited by 96
Microenvironmental influences of apoptosis in vivo and in vitro
Gregory, C. D., & Pound, J. D. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0485-9 · Cited by 114
Laoui, D., Overmeire, E. V., Movahedi, K., den Bossche, J. V., Schouppe, E., Mommer, C., Nikolaou, A., Morias, Y., BAETSELIER, P. D., & Ginderachter, J. A. V. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.06.007 · Cited by 114
“As a matter of fact, NF-"B activation in TAM was shown to be instrumental for their M2-like phenotype, by inhibiting STAT1 signaling (Hagemann et al. 2008).”
BackgroundHacking the host: exploitation of macrophage polarization by intracellular bacterial pathogens
Thiriot, J. D., Martinez-Martinez, Y. B., Endsley, J. J., & Torres, A. G. (2020) · Pathogens and Disease · doi:10.1093/femspd/ftaa009 · Cited by 103
“Due to a significant capacity for plasticity, macrophages can shift polarization states (e.g. macrophage repolarization of an M2 to an M1) depending on the environmental cues present (Hagemann et al. 2008; Duluc et al. 2009).”
BackgroundWatari, K., Shibata, T., Kawahara, A., Sata, K.-I., Nabeshima, H., Shinoda, A., Abe, H., Azuma, K., Murakami, Y., Izumi, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099568 · Cited by 102
Azhdari, S., Moghaddam, A. S., Abdollahi, E., Johnston, T. P., Ghaneifar, Z., Vahedi, P., & Goleij, P. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220324114624 · Cited by 110
CD163L1 and CLEC5A discriminate subsets of human resident and inflammatory macrophages in vivo
González-Domínguez, É., Samaniego, R., Flores-Sevilla, J. L., Campos-Campos, S. F., Gómez-Campos, G., Salas, A., Campos-Peña, V., Corbí, Á. L., Sánchez-Mateos, P., & Sánchez-Torres, C. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi1114-531r · Cited by 104
“However, TAMs also develop antitumor activity that could be ascribed to M1 Mfs, because they are able to kill tumor cells, stimulate antitumor Th1 responses, and ameliorate TAM suppressive activities [21, 22].”
BackgroundBarber, A., Rynda, A., & Sentman, C. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902000 · Cited by 103
Mukherjee, S., Fried, A., Hussaini, R., White, R., Baidoo, J., Yalamanchi, S., & Banerjee, P. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0792-5 · Cited by 105
“intra-peritoneal infusion of IL12 ab On day 11 and day 14 from implantation of 10(5) GL261 cells, each mouse in the CCP + IL12Ab group received intra-peritoneal infusion of the IL12-neutralizing Anti-IL12 (p40/p70) antibody (rat IgG) (BD, Catalog# 554475) (100 μg per mouse) [27, 29].”
BackgroundMethodResultInfluentialTargeting tumor-associated macrophages to combat pancreatic cancer
Cui, R., Yue, W., Lattime, E. C., Stein, M. N., Xu, Q., & Tan, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9383 · Cited by 110
Yang, X., Feng, W., Wang, R., Yang, F., Wang, L., Chen, S., Ru, Y., Cheng, T., & Zheng, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1412910 · Cited by 101
TAMing pancreatic cancer: combat with a double edged sword
Lankadasari, M. B., Mukhopadhyay, P., Mohammed, S., & Harikumar, K. B. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0966-6 · Cited by 94
“This re-education of TAMs occurs via inhibition of the NF-κB pathway [110].”
BackgroundReprogramming the tumor microenvironment by genome editing for precision cancer therapy
Liu, K., Cui, J., Zhan, Y., Ouyang, Q., Lu, Q., Yang, D., Li, X., & Yin, J. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01561-5 · Cited by 113
Tumor-Associated Macrophages Are Related to Volumetric Growth of Vestibular Schwannomas
de Vries, M. W., Bruijn, I. H. B., Malessy, M. J. A., de Bruïne, S. F. T., van der Mey, A. G. L., & Hogendoorn, P. C. W. (2013) · Otology & Neurotology · doi:10.1097/mao.0b013e31827c9fbf · Cited by 99
Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation
Adamson, S. E., Griffiths, R., Moravec, R., Senthivinayagam, S., Montgomery, G., Chen, W., Han, J., Sharma, P. R., Mullins, G. R., Gorski, S. A., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci79590 · Cited by 98
Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease
Lameijer, M. A., Tang, J., Nahrendorf, M., Beelen, R. H. J., & Mulder, W. J. M. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2013.819216 · Cited by 97
Cytokines: Can Cancer Get the Message?
Morris, R. M., Mortimer, T. O., & O'Neill, K. L. (2022) · Cancers · doi:10.3390/cancers14092178 · Cited by 110
“TNF-α antagonists may be used to neutralize TNF-α and reprogram the TME to become more antitumor-like [129,130].”
MethodCancer secretome and inflammation: The bright and the dark sides of NF-κB
Capece, D., Verzella, D., Tessitore, A., Alesse, E., Capalbo, C., & Zazzeroni, F. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.08.004 · Cited by 90
Guo, J., Duan, Z., Zhang, C., Wang, W., He, H., Liu, Y., Wu, P. S., Wang, S., Song, M., Chen, H., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901104 · Cited by 101
Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression
Bąk, S., Alonso, A., Turk, M. J., & Berwin, B. L. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.08.266 · Cited by 101
“The spleens from ID8 tumor-bearing (C) and ing mice contain a greater total number of splenic CD11b+Gr-1+ cells (E). efined by CD11b expression, described by others as ID8-recruited AM (Hagemann et al., 2008).”
Finkernagel, F., Reinartz, S., Lieber, S., Adhikary, T., Wortmann, A., Hoffmann, N., Bieringer, T., Nist, A., Stiewe, T., Jansen, J. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12180 · Cited by 94
Metabolic reprograming of tumor-associated macrophages
Puthenveetil, A., & Dubey, S. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-2037 · Cited by 108
“Another dimension in TAM targeted therapeutics is aimed at disrupting the crosstalk between TAMs and other malignant cells; these include blocking TAM derived cytokines/chemokines (175,176), inhibition of adhesion molecule such as VCAM1 on malignant cells or inhibition of NF-κB mediated transcriptional program in TAMs…”
BackgroundMerecz-Sadowska, A., Sitarek, P., Śliwiński, T., & Zajdel, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249605 · Cited by 100
“It was shown that inhibition of IKKβ in tumor-associated macrophages switched the macrophage phenotype from M2 to M1, that was related to increased IL-12 and iNOS release [64].”
BackgroundTPL2 kinase regulates the inflammatory milieu of the myeloma niche
Hope, C. L., Ollar, S. J., Héninger, E., Hebron, E., Jensen, J. L., Kim, J., Maroulakou, I. G., Miyamoto, S., Leith, C. P., Yang, D. T., et al. (2014) · Blood · doi:10.1182/blood-2014-02-554071 · Cited by 99
“In established tumors, Tpl2 loss promotedmacrophage repolarization toward theM1 phenotype, consistent with the notion that IKK-b–dependent pathways promoteM2macrophagepolarization in tumors.(82,83)M1-repolarization together with a defect in inflammatory cytokine production represents the reverse of “MSC-educated” macr…”
BackgroundPark, J., Lee, S. E., Hur, J., Hong, E. B., Choi, J.-I., Yang, J.-M., Kim, J.-Y., Kim, Y.-C., Cho, H.-J., Peters, J. M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.024 · Cited by 91
“However, themolecular determinants of the diverse pro-tumoral phenotypes in tumor microenvironment have been incompletely understood, though there are several candidates such as NF-kappaB (Hagemann et al., 2008), STAT3 (Kujawski et al.”
BackgroundCornelissen, R., Lievense, L. A., Maat, A. P., Hendriks, R. W., Hoogsteden, H. C., Bogers, A. J., Hegmans, J. P., & Aerts, J. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106742 · Cited by 91
Wang, T.-Q., Zhang, J., Hou, T., Yin, X., & Zhang, N. (2019) · Nanoscale · doi:10.1039/c9nr03374b · Cited by 78
Endocytosis of Particle Formulations by Macrophages and Its Application to Clinical Treatment
Hirota, K., & Ter, H. (2012) · Molecular Regulation of Endocytosis · doi:10.5772/45820 · Cited by 90
“In addition, “re-education” of the healing-type macrophages (M2 macrophages) to the killer-type macrophages (M1 macrophages) by immunomodulators should be effective as well [96].”
Li, Y., He, Y., Miao, K., Zheng, Y., Deng, C., & Liu, T. (2020) · Theranostics · doi:10.7150/thno.40495 · Cited by 97
Deciphering the role of Nuclear Factor-κB in cellular senescence
Vaughan, S., & Jat, P. S. (2011) · Aging · doi:10.18632/aging.100390 · Cited by 86
“It has also been argued that deletion of IKKβ can induce an antitumourigenic phenotype [23], though this may be independent of NF-κB as IKKs can also function separately of NF-κB signalling.”
BackgroundChamseddine, A. N., Assi, T., Mir, O., & Chouaïb, S. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107986 · Cited by 94
Protein Kinase Cζ Represses the Interleukin-6 Promoter and Impairs Tumorigenesis In Vivo
Galvez, A. S., Durán, Á., Linares, J. F., Pathrose, P., Castilla, E. A., Abu‐Baker, S., Leitges, M., Díaz-Meco, M. T., & Moscat, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01294-08 · Cited by 91
Lizotte, P. H., Baird, J. R., Stevens, C. A., Lauer, P., Green, W. R., Brockstedt, D. G., & Fiering, S. (2014) · OncoImmunology · doi:10.4161/onci.28926 · Cited by 89
NF-κB in Cancer Immunity: Friend or Foe?
Lalle, G., Twardowski, J., & Grinberg‐Bleyer, Y. (2021) · Cells · doi:10.3390/cells10020355 · Cited by 87
“Cell therapy using Ikbkb or Nfkb1‐deficient macrophages favors strong anti‐tumor immunity and tumor rejection [27,35].”
BackgroundTumor‐associated macrophages: An important player in breast cancer progression
Huang, X., Cao, J., & Zu, X. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.14268 · Cited by 92
Regulation of the IL-10-driven macrophage phenotype under incoherent stimuli
Chuang, Y., Hung, M. E., Cangelose, B. K., & Leonard, J. N. (2016) · Innate Immunity · doi:10.1177/1753425916668243 · Cited by 81
The resolution of inflammation and cancer
Rodríguez‐Vita, J., & Lawrence, T. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.006 · Cited by 100
“Our recent studies in a model of ovarian cancer also suggest that the activation of NF-kB through IKKb maintains tumor-promoting function of TAM [24].”
BackgroundSelf-citationInterferons Direct an Effective Innate Response to Legionella pneumophila Infection
Plumlee, C. R., Lee, C., Beg, A. A., Decker, T., Shuman, H. A., & Schindler, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018283 · Cited by 80
Mukherjee, S., Hussaini, R., White, R., Atwi, D., Fried, A., Sampat, S., Piao, L., Pan, Q., & Banerjee, P. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2130-3 · Cited by 86
“5, 6), we also probed for tumorinfiltrating activated NK cells in these xenograft tumors [29, 34, 39].”
BackgroundInfluentialvan der Sluis, T. C., Sluijter, M., van Duikeren, S., West, B. L., Melief, C. J. M., Arens, R., van der Burg, S. H., & van Hall, T. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0052 · Cited by 91
“Skewing TAMs toward this "classically" activated phenotype can result in antitumor activity and clearance of established tumors, indicating that tumor-associated myeloid cells might hold the key to switching the local immune system to a tumor-rejection response (14, 15).”
BackgroundMethodChung, S., Ranjan, R., Lee, Y. G., Park, G. Y., Karpurapu, M., Deng, J., Xiao, L., Kim, J. Y., Unterman, T. G., & Christman, J. W. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0514-251r · Cited by 83
Ni, Y., Zhuge, F., Nagashimada, M., & Ota, T. (2016) · Nutrients · doi:10.3390/nu8070391 · Cited by 90
“TLR‐mediated NF‐κB activation can produce inflammatory mediators associated with M1 macrophages, but can also activate genetic programs essential for the resolution of inflammation and M2 polarization [62].”
BackgroundCzauderna, C., Castven, D., Mahn, F. L., & Marquardt, J. U. (2019) · Cancers · doi:10.3390/cancers11081053 · Cited by 92
“NF-κB, especially canonical subunit p50, has been associated in macrophage polarization and blocking NF-κB in activated tumor-associated macrophages can convert them from an immunosuppressive M2 phenotype back to M1-like cytotoxic cells [90,91].”
BackgroundLactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors
Seow, S. W., Cai, S., Rahmat, J. N., Bay, B. H., Lee, Y. K., Chan, Y. H., & Mahendran, R. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01426.x · Cited by 78
Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases
Cook, L. M., Shay, G., Aruajo, A., & Lynch, C. C. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9494-4 · Cited by 90
“Inhibition of NFκB in TAMs resulted in the expression of pro-inflammatory cytokines such as IL-12 that were cytotoxic to tumor cells [89].”
Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma
Chiu, K., Lee, C.-H., Liu, S.-Y., Chou, Y., Huang, R., Huang, S., & Shieh, Y. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.04.004 · Cited by 84
“has demonstrated that target NF-jB in TAMs maintained the classical M1 phenotype and promoted tumor killing [45].”
BackgroundImmune Cell Population in Ovarian Tumor Microenvironment
Cai, D. L., & Jin, L. (2017) · Journal of Cancer · doi:10.7150/jca.20314 · Cited by 84
“Blocking NF-κB signaling pathways in ovarian TAMs decreases the level of M2-associated cytokines and increases M1-associated IL-12 and NOS, consequently preventing tumor cell invasion [28].”
BackgroundThe inflammatory microenvironment in vestibular schwannoma
Hannan, C. J., Lewis, D. G., O’Leary, C., Donofrio, C. A., Evans, D. G., Roncaroli, F., Brough, D., King, A. T., Coope, D. J., & Pathmanaban, O. N. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa023 · Cited by 102
Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment
Rodriguez, Y. I., Campos, L. E., Castro, M. G., Al-Adhami, A., Oskeritzian, C. A., & Alvarez, S. E. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00218 · Cited by 87
“Indeed, NF-κB activation in macrophages also promoted the switch toward an M2 phenotype (157).”
BackgroundCD14 is critical for TLR2-mediated M1 macrophage activation triggered by N-glycan recognition
da Silva, T. A., Zorzetto-Fernandes, A. L., Cecílio, N. T., Sardinha-Silva, A., Fernandes, F. F., & Roque‐Barreira, M. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-07397-0 · Cited by 85
Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment
Malekghasemi, S., Majidi, J., Baghbanzadeh, A., Abdolalizadeh, J., Baradaran, B., & Maleki, L. A. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.066 · Cited by 89
Exploiting inflammation for therapeutic gain in pancreatic cancer
Steele, C. W., Jamieson, N. B., Evans, T. R. J., McKay, C. J., Sansom, O. J., Morton, J. P., & Carter, C. R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.24 · Cited by 88
“Hagemann et al (2008) have suggested that macrophages may be re-educated towards an antitumour function through control of NF-kB activity.”
BackgroundSilva, V. L., & Al-Jamal, W. T. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.013 · Cited by 78
“They over-express scavenger receptors, mannose receptors and exhibit anti-inflammatory activity [94, 95].”
BackgroundPetruzzi, M. N. M. R., Cherubini, K., Salum, F. G., & de Figueiredo, M. A. Z. (2017) · Diagnostic Pathology · doi:10.1186/s13000-017-0623-6 · Cited by 83
“Gas-6/Axl and NF-κB may be interesting targets for therapeutic intervention, since NF-κB promotes cancer resistance to apoptosis and production of growth factors in the stroma, which stimulates tumour progression [31].”
BackgroundOlsson, A., Nakhlé, J., Sundstedt, A., Plas, P., Bauchet, A.-L., Pierron, V., Bruetschy, L., Deronic, A., Törngren, M., Liberg, D., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-015-0098-5 · Cited by 78
“For instance, it has been shown that sustained nuclear expression of p50 NFκB homodimer results in a M2 phenotype [17], while by targeting IKKβ and thereby inhibiting NF-κB activity, M2 TAMs could be converted into macrophages of the M1 phenotype [18, 19].”
BackgroundLi, D., Wang, X., Wu, J., Quan, W., Ma, L., Yang, F., Wu, K., & Wan, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056616 · Cited by 78
Toll-like Receptor 4 Signaling Promotes Tumor Growth
Lee, C., Wu, C., & Shiau, A. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181b7a0a4 · Cited by 85
“The strategies for altering the expression and activation of NF-kB in tumor cells and macrophages have been shown to be effective in inhibiting tumor growth.(1,7,8) The innate immune system recognizes the presence of pathogens through the expression of a family of membrane receptors known as Toll-like receptors (TLRs).”
MethodLian, J., Liang, Y., Zhang, H., Lan, M., Ye, Z., Lin, B., Qiu, X., & Zeng, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912279 · Cited by 84
Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer
Deka, K., & Li, Y. (2023) · Cells · doi:10.3390/cells12050788 · Cited by 82
Liu, H., Wang, J., Zhang, M., Xuan, Q., Wang, Z., Lian, X., & Zhang, Q. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4394-2 · Cited by 78
Ortega, R. A., Barham, W. J., Sharman, K., Tikhomirov, O., Giorgio, T. D., & Yull, F. E. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s93483 · Cited by 82
Interaction of monocytes/macrophages with ovarian cancer cells promotes angiogenesis in vitro
Wang, X., Zhao, X., Wang, K., Wu, L., & Duan, T. (2013) · Cancer Science · doi:10.1111/cas.12110 · Cited by 73
Tumor cells induce LAMP2a expression in tumor-associated macrophage for cancer progression
Wang, R., Liu, Y., Liu, L., Chen, M., Wang, X., Yang, J., Gong, Y., Ding, B.-S., Wei, Y., & Wei, X. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.045 · Cited by 74
Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment
Luo, Y., Yang, J., Yu, J., Liu, X., Yu, C., Hu, J., Shi, H., & Ma, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00048 · Cited by 81
One microenvironment does not fit all: heterogeneity beyond cancer cells
Kim, I. S., & Zhang, X. H.-F. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9643-z · Cited by 81
Role of tumor microenvironment in ovarian cancer pathobiology
Ghoneum, A., Afify, H. M. A., Salih, Z. T., Kelly, M., & Said, N. A. (2018) · Oncotarget · doi:10.18632/oncotarget.25126 · Cited by 83
Tumor accomplice: T cell exhaustion induced by chronic inflammation
Fang, L., Liu, K., Liu, C., Wang, X., Ma, W., Xu, W., Wu, J., & Sun, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.979116 · Cited by 77
Lee, Y., Chittezhath, M., Andrè, V., Zhao, H. W., Poidinger, M., Biondi, A., D’Amico, G., & Biswas, S. K. (2011) · Blood · doi:10.1182/blood-2011-06-357442 · Cited by 78
Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrate
Arwert, E. N., Lal, R., Quist, S., Rosewell, I., van Rooijen, N., & Watt, F. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007404107 · Cited by 73
“In particular, M2 polarized tumor-associated macrophages (TAMs) are known to drive tumor progression by stimulating angiogenesis and suppressing anti-tumor immunity (32, 33).”
BackgroundCarcinoma origin dictates differential skewing of monocyte function
Bögels, M., Braster, R., Nijland, P. G., Gül, N., van de Luijtgaarden, W., Fijneman, R. J. A., Meijer, G. A., Jimenez, C. R., Beelen, R. H. J., & van Egmond, M. (2012) · OncoImmunology · doi:10.4161/onci.20427 · Cited by 73
Macrophage Inhibitory Cytokine-1: Possible Bridge Molecule of Inflammation and Prostate Cancer
Karan, D., Holzbeierlein, J. M., & Thrasher, J. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1230 · Cited by 72
Metadata
- Authors
- Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R.
- Affiliations
- Queen Mary University of London (GB)
- 1Centre for Cancer and Inflammation
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-05-19
- Volume
- 205
- Issue
- 6
- Pages
- 1261-1268
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2413024
- OpenAlex
- W2105724560
- Cited by
- 792
- References
- 25
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 32 · 2023: 28 · 2022: 42 · 2021: 41 · 2020: 45 · 2019: 31 · 2018: 50 · 2017: 49 · 2016: 49 · 2015: 46 · 2014: 73 · 2013: 64 · 2012: 41
- FWCI
- 23.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Wellcome Trust
- Cancer Research UK
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- tumor-associated macrophages, NF-κB signaling, macrophage polarization, alternative macrophage activation, IκB kinase β, MyD88, interleukin-1 receptor, IL-12, NK cell recruitment, tumor immunosuppression, tumor microenvironment, antitumor immunity, tumor regression
- MeSH terms
- Animals, Cell Differentiation, Humans, Immunosuppression Therapy, Macrophages, Neoplasms, Phenotype, Signal Transduction, NF-kappa B, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.